Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

FDA's regulatory shift on tobacco control.

Y Tony Yang1

  • 1Department of Health Administration and Policy, George Mason University, Fairfax, VA 22030, USA.

Preventive Medicine
|June 6, 2018
PubMed
Summary

The U.S. Food and Drug Administration (FDA) aims to reduce cigarette nicotine levels and delay e-cigarette regulations. This strategy seeks to decrease smoking-related deaths and diseases by guiding smokers to less harmful nicotine alternatives.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The economic and health consequences of shared clinical decision-making for hepatitis B birth dose vaccination.

Journal of medical economics·2026
Same author

The Political Determinants of Obstetric Prescribing.

Obstetrics and gynecology·2026
Same author

When Task Shifting Becomes Responsibility Laundering.

The American journal of bioethics : AJOB·2026
Same author

Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United States.

Journal of psychoactive drugs·2026
Same author

Latent profile analysis of personality characteristics among US young adults in relation to cannabis use and intentions over time.

Addictive behaviors·2026
Same author

Re--ations for nursing as the stabilizing force in U.S. immunization in a fractured era.

Nursing outlook·2026

Area of Science:

  • Public Health
  • Regulatory Science
  • Addiction Medicine

Background:

  • The Food and Drug Administration (FDA) is implementing a comprehensive strategy to combat smoking-related deaths and diseases.
  • This strategy includes reducing nicotine levels in cigarettes and delaying regulations for certain tobacco products.

Purpose of the Study:

  • To outline the FDA's new approach to tobacco control, focusing on reducing addiction and harm.
  • To highlight the potential benefits and remaining challenges of this regulatory shift.

Main Methods:

  • Policy analysis of FDA announcements regarding nicotine reduction and e-cigarette regulation.
  • Review of the public health implications of shifting smokers to alternative nicotine products.

Main Results:

  • The FDA announced plans to reduce cigarette nicotine content and postpone regulatory approval for cigars and e-cigarettes.
  • These actions are part of a broader plan to transition smokers away from conventional cigarettes.

Conclusions:

  • The FDA's new approach represents significant progress in addressing smoking-related health issues.
  • Further research on e-cigarette safety, public education, and industry collaboration are crucial for success.

Related Experiment Videos